Thiazolyl urea compounds and methods of uses
1 Assignment
0 Petitions
Accused Products
Abstract
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
-
Citations
17 Claims
-
1. A compound of formula VI
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
2. A compound of claim 1 wherein R15 is selected from H, optionally substituted pyrrolidinyl, optionally substituted piperazinyl, optionally substituted piperidinyl, morpholinyl, 1,2,3,6-tetrahydro-pyridinyl, (optionally substituted pyrrolidinyl) -C1-C2-alkyl, (optionally substituted piperidinyl) -C1-C2-alkyl, (optionally substituted piperazinyl) -C1-C2-alkyl, morpholinyl-C1-C2-alkyl, C1-C4-alkylamino-C1-C4-alkyl, C1-C4-hydroxyalkylamino, (optionally substituted pyrrolidinyl) -C1-C2-alkylamino, (optionally substituted piperidinyl) -C1-C2-alkylamino, (optionally substituted piperazinyl) -C1-C2-alkylamino, morpholinyl-C1-C2-alkylamino, optionally substituted pyrrolidinyl-C1-C4-alkoxy, optionally substituted azetidinyl-C1-C4-alkoxy, tetrahydrofuryl-C1-C4-alkoxy, optionally substituted piperidinyl-C1-C4-alkoxy, C1-C4-alkylamino-C1-C4-alkoxy, tetrahydrofuryloxy, optionally substituted piperidinyloxy, optionally substituted phenoxy, C1-C4-alkylaminocarbonyl and C1-C4-alkylaminothiocarbonyl;
- wherein R16 is selected from H, 5-6-membered nitrogen containing heterocyclylcarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-alkylaminomethyl, and 5-6-membered nitrogen containing heterocyclylmethyl; and
wherein R17 is selected from halo, C1-C2-alkyl, optionally substituted 5-6-membered heteroarylsulfonyl-C1-C2-alkyl, optionally substituted phenoxy, and C3-C6-cycloalkyl-C2-C4-alkynyl; and
pharmaceutically acceptable derivatives thereof.
- wherein R16 is selected from H, 5-6-membered nitrogen containing heterocyclylcarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-alkylaminomethyl, and 5-6-membered nitrogen containing heterocyclylmethyl; and
-
3. A compound of claim 2 wherein R15 is selected from H, tetrahydro-furanyloxy, l-methylpyrrolidin-2-ylmethoxy, 2-pyrrolidinylmethoxy, 3-pyrrolidinylmethoxy, 1-Boc-pyrrolidin-2-ylmethoxy, 4-piperidinylmethoxy, 1-Boc-piperidin-4-ylmethoxy, 1-Boc-piperidin-4-ylethoxy, piperidin-4-ylethoxy, 1-methyl-piperidin-4-ylmethoxy, 1-Boc-azetidin-3-ylmethoxy, 1-methyl-azetidin-3-ylmethoxy, 3-azetidinylmethoxy, l-methyl-piperidin-4-yloxy, phenyloxy, 4-(pyrrolidin-1-ylmethyl)phenoxy, dimethylaminoethoxy, 1piperidinylmethyl, 1-(piperidin-1-yl)ethyl, 3-methylpiperidin-1-ylmethyl, 1-pyrrolidinylmethyl, 2,2,6,6-tetramethylpiperidin-1-ylmethyl, 2,6-dimethylpiperidin-1-ylmethyl, dimethylaminomethyl, diethylaminomethyl, diethylaminothiocarbonyl, diethylaminocarbonyl, N-Boc-N-isopropylaminomethyl, isopropylaminomethyl, 2-thienylsulfonylmethyl, hydroxypropylamino, 4-ethyl-piperidin-1-yl, 4-(2-pyridyl)piperidin-1-yl, 1-methylpiperidin-4-yl, 4-(2-pyrazinyl)piperidin-1-yl, 1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl, 1,2,3,6-tetrahydro-pyridin-4-yl, and 1-Boc-1,2,3,6-tetrahydro-pyridin-4-yl;
wherein R16 is selected from H, 1-piperidinylcarbonyl, diethylaminocarbonyl, diethylaminomethyl, 1-piperidinylmethyl; and
wherein R17 is selected from chloro, bromo, methyl and cyclopropylethynyl; and
pharmaceutically acceptable derivatives thereof.
-
4. A compound of claim 3 wherein R17 is chloro or bromo;
- and pharmaceutically acceptable derivatives thereof.
-
5. A compound of claim 1 wherein R15 is selected from H, optionally substituted pyrrolidinyl, optionally substituted piperazinyl, optionally substituted piperidinyl, morpholinyl, 1,2,3, 6-tetrahydro-pyridinyl, (optionally substituted pyrrolidinyl) -C1-C2-alkyl, (optionally substituted piperidinyl) -C1-C2-alkyl, (optionally substituted piperazinyl) -C1-C2-alkyl, morpholinyl-C1-C2-alkyl, (optionally substituted pyrrolidinyl) -C1-C2-alkylamino, (optionally substituted piperidinyl) -C1-C2-alkylamino, (optionally substituted piperazinyl)-C1-C2-alkylamino, morpholinyl-C1-C2-alkylamino, C1-C4-alkylamino-C1-C4-alkyl, C1-C4-hydroxyalkylamino, optionally substituted pyrrolidinyl-C1-C4-alkoxy, optionally substituted azetidinyl-C1-C4-alkoxy, tetrahydrofuryl-C1-C4-alkoxy, optionally substituted piperidinyl-C1-C4-alkoxy, C1-C4-alkylamino-C1-C4-alkoxy, tetrahydrofuryloxy, optionally substituted piperidinyloxy, optionally substituted phenoxy, C1-C4-alkylaminocarbonyl and C1-C4-alkylaminothiocarbonyl;
- wherein R16 is selected from H, 5-6-membered nitrogen containing heterocyclylcarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-alkylaminomethyl, and 5-6-membered nitrogen containing heterocyclylmethyl; and
wherein R17 is selected from C3-C6-cycloalkyl and phenyl optionally substituted with one or two substituents selected from halo,C1-C4-alkylamino, amino, nitro, C1-C4-alkoxy, C1-C2-haloalkyl, hydroxy, C1-C4-alkylthio, C1-C4-alkylcarbonylamino, (optionally substituted phenyl)sulfonylamino, cyano, C1-C2-haloalkoxy, 5- or 6-membered N-containing heterocyclyl, aminosulfonyl, (6-membered N-containing heterocyclyl)sulfonyl, C1-C2-haloalkylcarbonylaminosulfonyl and (optionally substituted phenyl)aminosulfonyl;
and pharmaceutically acceptable derivatives thereof.
- wherein R16 is selected from H, 5-6-membered nitrogen containing heterocyclylcarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-alkylaminomethyl, and 5-6-membered nitrogen containing heterocyclylmethyl; and
-
6. A compound of claim 5 wherein R15 is selected from H, tetrahydro-furanyloxy, l-methylpyrrolidin-2-ylmethoxy, 2-pyrrolidinylmethoxy, 3-pyrrolidinylmethoxy, 1-Boc-pyrrolidin-2-ylmethoxy, 4-piperidinylmethoxy, 1-Boc-piperidin-4-ylmethoxy, 1-Boc-piperidin-4-ylethoxy, piperidin-4-ylethoxy, 1-methyl-piperidin-4-ylmethoxy, 1-Boc-azetidin-3-ylmethoxy, 1-methyl-azetidin-3-ylmethoxy, 3-azetidinylmethoxy, 1-methyl-piperidin-4-yloxy, phenyloxy, 4-(pyrrolidin-1-ylmethyl)phenoxy, dimethylaminoethoxy, 1-piperidinylmethyl, 1-(piperidin-1-yl)ethyl, 3-methylpiperidin-1-ylmethyl, 1-pyrrolidinylmethyl, 2,2,6,6-tetramethylpiperidin-1-ylmethyl, 2,6-dimethylpiperidin-1-ylmethyl, dimethylaminomethyl, diethylaminomethyl, diethylaminothiocarbonyl, diethylaminocarbonyl, N-Boc-N-isopropylaminomethyl, isopropylaminomethyl, 2-thienylsulfonylmethyl, hydroxypropylamino, 4-ethyl-piperidin-1-yl, 4-(2-pyridyl)piperidin-1-yl, 1-methylpiperidin-4-yl, 4-(2-pyrazinyl)piperidin-1-yl, 1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl, 1,2,3,6-tetrahydro-pyridin-4-yl, and 1-Boc-1,2,3,6-tetrahydro-pyridin-4-yl;
- wherein R16 is selected from H, 1-piperidinylcarbonyl, diethylaminocarbonyl, diethylaminomethyl, 1-piperidinylmethyl; and
wherein R17 is selected from cyclopropyl and phenyl optionally substituted with aminosulfonyl; and
pharmaceutically acceptable derivatives thereof.
- wherein R16 is selected from H, 1-piperidinylcarbonyl, diethylaminocarbonyl, diethylaminomethyl, 1-piperidinylmethyl; and
-
7. A compound of claim 6 wherein R17 is unsubstituted phenyl;
- and pharmaceutically acceptable derivatives thereof.
-
8. Compound of claim 1 wherein R15 is selected from H, optionally substituted pyrrolidinyl, optionally substituted piperazinyl, optionally substituted piperidinyl, morpholinyl, 1,2,3,6-tetrahydro-pyridinyl, (optionally substituted pyrrolidinyl)-C1-C2-alkyl, (optionally substituted piperidinyl)-C1-C2-alkyl, (optionally substituted piperazinyl)-C1-C2-alkyl, morpholinyl-C1-C2-alkyl, (optionally substituted pyrrolidinyl)-C1-C2-alkylamino, (optionally substituted piperidinyl)-C1-C2-alkylamino, (optionally substituted piperazinyl)-C1-C2-alkylamino, morpholinyl-C1-C2-alkylamino, C1-C4-alkylamino-C1-C4-alkyl, C1-C4-hydroxyalkylamino, optionally substituted pyrrolidinyl-C1-C4-alkoxy, optionally substituted azetidinyl-C1-C4-alkoxy, tetrahydrofuryl-C1-C4-alkoxy, optionally substituted piperidinyl-C1-C4-alkoxy, C1-C4-alkylamino-C1-C4-alkoxy, tetrahydrofuryloxy, optionally substituted piperidinyloxy, optionally substituted phenoxy, C1-C4-alkylaminocarbonyl and C3-C4-alkylaminothiocarbonyl;
- wherein R16 is selected from H, 5-6-membered nitrogen containing heterocyclylcarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-alkylaminomethyl, and 5-6-membered nitrogen containing heterocyclylmethyl; and
wherein R17 is selected from optionally substituted indazolyl, optionally substituted indolyl, unsubstituted 5-membered oxygen or sulfur containing heteroaryl, unsubstituted 6-membered nitrogen-containing heterocyclyl, and 6-membered nitrogen-containing heterocyclyl substituted with one or more substituents independently selected from pyridyl, phenyl,C1-C4 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy, amino, halo, piperidinyl, morpholinyl, C1-C2 alkylpiperazinyl, C1-C3 alkylaminothiocarbonyl, N,N-di-C1-C2-alkylamino-C1-C4-alkylenyl, N—
C1-C2-alkylamino-C1-C4-alkylenyl, morpholinyl-C1-C4-alkylenylaminocarbonyl, aminocarbonyl, C1-C2-haloalkylcarbonylamino, morpholinyl-C1-C4-alkylenylamino, N,N-di-C1-C2-alkylamino and N,N-di-C1-C2-alkylamino-C1-C4-alkylenylamino;
and pharmaceutically acceptable derivatives thereof.
- wherein R16 is selected from H, 5-6-membered nitrogen containing heterocyclylcarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-alkylaminomethyl, and 5-6-membered nitrogen containing heterocyclylmethyl; and
-
9. Compound of claim 8 wherein R15 is selected from H, tetrahydro-furanyloxy, 1-methylpyrrolidin-2-ylmethoxy, 2-pyrrolidinylmethoxy, 3-pyrrolidinylmethoxy, 1-Boc-pyrrolidin-2-ylmethoxy, 4-piperidinylmethoxy, 1-Boc-piperidin-4-ylmethoxy, 1-Boc-piperidin-4-ylethoxy, piperidin-4-ylethoxy, 1-methyl-piperidin-4-ylmethoxy, 1-Boc-azetidin-3-ylmethoxy, 1-methyl-azetidin-3-ylmethoxy, 3-azetidinylmethoxy, 1-methyl-piperidin-4-yloxy, phenyloxy, 4-(pyrrolidin-1-ylmethyl)phenoxy, dimethylaminoethoxy, 1-piperidinylmethyl, 1-(piperidin-1-yl)ethyl, 3-methylpiperidin-1-ylmethyl, 1-pyrrolidinylmethyl, 2,2,6,6-tetramethylpiperidin-1-ylmethyl, 2,6-dimethylpiperidin-1-ylmethyl, dimethylaminomethyl, diethylaminomethyl, -diethylaminothiocarbonyl, diethylaminocarbonyl, N-Boc-N-isopropylaminomethyl, isopropylaminomethyl, 2-thienylsulfonylmethyl, hydroxypropylamino, 4-ethyl-piperidin-1-yl, 4-(2-pyridyl)piperidin-1-yl, 1-methylpiperidin-4-yl, 4-(2-pyrazinyl)piperidin-1-yl, 1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl, 1,2,3,6-tetrahydro-pyridin-4-yl, and 1-Boc-1,2,3,6-tetrahydro-pyridin-4-yl;
- wherein R16 is selected from H, 1-piperidinylcarbonyl, diethylaminocarbonyl, diethylaminomethyl, 1-piperidinylmethyl; and
wherein R17 is selected from 5-indazolyl, l-Boc-indol-5-yl, unsubstituted thienyl, 5-tert-butyloxazol-2-yl and 4-pyridyl substituted with one or more substituents independently selected from methoxy and chloro; and
pharmaceutically acceptable derivatives thereof.
- wherein R16 is selected from H, 1-piperidinylcarbonyl, diethylaminocarbonyl, diethylaminomethyl, 1-piperidinylmethyl; and
-
10. A compound of claim 9 wherein R17 is 4-pyridyl;
- and pharmaceutically acceptable derivatives thereof.
-
11. Compound of claim 1 and pharmaceutically acceptable derivatives thereof selected from:
-
1-[6-(3-Methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[4-(Piperidine-1-carbonyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(2-Chloro-thiazol-4-yl)-3-[4-(piperidine-1-carbonyl)-pyridin-2-yl]-urea;
N,N-Diethyl-2-[3-(2-pyridin-4-yl-thiazol-4-yl)-ureido]-isonicotinamide;
N,N-Diethyl-2-[3-(2-phenyl-thiazol-4-yl)-ureido]-isonicotinamide;
2-[3-(2-Bromo-thiazol-4-yl)-ureido]-N,N-diethyl-isonicotinamide;
1-(4-Diethylaminomethyl-pyridin-2-yl)-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(2,6-Dimethyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Piperidin-1-yl-ethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
2-({6-[3-(2-Pyridin-4-yl-thiazol-4-yl)-ureido]-pyridin-2-ylamino)-methyl)-piperidine-1-carboxylic acid tert-butyl ester;
1-[6-[(Piperidin-2-ylmethyl)-amino]-pyridin-2-yl}-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
(S)-1-[6-(3-Methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
(R)-1-[6-(3-Methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(2-Chloro-thiazol-4-yl)-3-(6-piperidin-1-ylmethyl-pyridin-2-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6-(2-piperidin-4-yl-ethoxy)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(2-piperidin-4-yl-ethoxy)-pyridin-2-yl]-urea;
1-[6-(Azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-bromo-thiazol-4-yl)-urea;
1-[6-(Azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-chloro-thiazol-4-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6-(piperidin-4-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(piperidin-4-ylmethoxy)-pyridin-2-yl]-urea;
tert-Butyl 3-{6-[3-(2-pyridin-4-yl-thiazol-4-yl)-ureido]-pyridin-2-yloxymethyl}-pyrrolidine-1-carboxylate;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-[6-(pyrrolidin-3-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-Cyclopropyl-thiazol-4-yl)-3-[6-(2-piperidin-4-yl-ethoxy)-pyridin-2-yl]-urea;
1-[6-(Isopropylamino-methyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(Isopropylamino-methyl)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6-(isopropylamino-methyl)-pyridin-2-yl]-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6-(1-methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(1-methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-phenylthiazol-4-yl)-3-(6-p-pyrrolidin-1-ylmethylphenoxypyridin-2-yl)urea;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-[6-(tetrahydro-furan-3-yloxy)-pyridin-2-yl]-urea;
1-[2-(1H-Indazol-5-yl)-thiazol-4-yl]-3-(6-piperidin-1-ylmethyl-pyridin-2-yl)-urea;
1-(1′
-Methyl-1′
,2′
,3′
,6′
-tetrahydro-[2,4′
]bipyridinyl-6-yl)-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(2-Bromo-thizol-4-yl)-3-(1′
-methyl-1′
,2′
,3′
,6′
-tetrahydro-[2,4′
]bipyridinyl-6-yl)-urea;
1-(1′
-Methyl-1′
,2′
,3′
,6′
-tetrahydro-2[2,4]bipyridinyl-6-yl)-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(3-Hydroxy-propylamino)-pyridin-2-yl]-3-(2-pyridin-4-yl-thizol-4-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6(3-hydroxy-propylamino)-pyridin-2-yl]-urea;
1-(1′
-Methyl-1′
,2′
,3′
,4′
,5′
,6′
-hexahydro-[2,4′
]bipydrinyl-6-yl)-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(1′
-Methyl-1′
,2′
,3′
,4′
,5′
,6′
-hexahydro-[2,4′
]bipyridinyl-6-yl)-3-(2-phenyl-thiazol-4-yl)-urea;
6-[3-(2-Pyridin-4-yl-thizol-4-yl)-ureido]-3′
,6′
-dihydro-2′
H-[2,4]bipyridinyl-1′
-carboxylic acid tert-butylester;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-(1′
,2′
,3′
,6′
-tetrahydro-[2,4′
]bipyridinyl-6-yl)-urea;
1-(2-Pyridin-4-yl-thizol-4-yl)-3-[6-(tetrahydro-furan-3-ylmethoxy)-pyridin-2-yl]-urea;
2-[6-[3-(2-Pyridin-4-yl-thiazol-4-yl)-ureido]-pyridin-2-yloxymethyl]-pyrrolidine-1-carboxylic acid tert-butyl ester;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-[6-(pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
6-[3-(2-Pyridin-4-yl-thiazol-4-yl)-ureido]-pyridine-2-carbothioic acid diethylamide;
1-(2-Bromo-thiazol-4-yl)-3-[6-(3-methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(3-methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-urea;
1-(2-Phenyl-thiazol-4-yl)-3-[4-(piperidine-1-carbonyl)-pyridin-2-yl]-urea;
1-(2-Bromo-thiazol-4-yl)-3-[4-(piperidine-1-carbonyl)-pyridin-2-yl]-urea;
1-[2-(2-Methoxy-pyridin-4-yl)-thiazol-4-yl]-3-(6-phenoxy-pyridin-2-yl)-urea;
1-[2-(2-Methoxy-pyridin-4-yl)-thiazol-4-yl]-3-[6-(1-methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
1-[6-(2-Dimethylamino-ethoxy)-pyridin-2-yl]-3-[2-(2-methoxy-pyridin-4-yl)-thiazol-4-yl]-urea;
1-[6-(1-Methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(2-phenylthiazol-4-yl)-3-(6-pyrrolidin-1-ylmethyl-pyridin-2-yl)urea;
1-(6-Diethylaminomethylpyridin-2-yl)-3-(2-phenylthiazol-4-yl)urea;
(S)-1-[6-(1-Methylpyrrolidin-2-ylmethoxy)pyridin-2-yl]-3-(2-phenylthiazol-4-yl)urea;
1-[6-(2-Piperidin-4-yl-ethoxy)pyridin-2-yl]-3-[2-phenylthiazol-4-yl]urea;
1-[6-(4-Ethylpiperazin-1-yl)-pyridin-2-yl]-3-(2-phenylthiazol-4-yl)urea;
Diethyl 6-[3-(2-phenylthiazol-4-yl)ureido]-pyridine-2-carboxamide;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-(6-p-pyrrolidin-1-ylmethylphenoxypyridin-2-yl)urea;
1-(2-Bromothiazol-4-yl)-3-(6-p-pyrrolidin-1-ylmethylphenoxypyridin-2-yl)urea;
1-[6-(Piperidin-4-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-piperidin-4-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-piperidin-4-yloxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(Azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-(2-Phenyl-thiazol-4-yl)-3-[6-(piperidin-4-ylmethoxy)-pyridin-2-yl]-urea;
1-[6-(1-Methyl-piperidin-4-ylmethoxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-piperidin-4-yloxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(2-Piperidin-4-yl-ethoxy)-pyridin-2-yl]-3-(2-thiophen-2-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-3-[2-(thiophene-2-sulfonylmethyl)-thiazol-4-yl]-urea;
1-[2-(2-Methoxy-pyridin-4-yl)-thiazol-4-yl]-3-(6-piperdin-1-ylmethyl-pyridin-2-yl)-urea; and
[2-(2-Chloro-pyridin-4-yl)-thiazol-4-yl]-3-(6-piperdin-1-ylmethyl-pyridin-2-yl)-urea.
-
-
12. Compound of claim 1 and pharmaceutically acceptable derivatives thereof selected from:
-
1-[6-(3-Methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[4-(Piperidine-1-carbonyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
N,N-Diethyl-2-[3-(2-pyridin-4-yl-thiazol-4-yl)-ureido]-isonicotinamide;
1-(4-Diethylaminomethyl-pyridin-2-yl)-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(2,6-Dimethyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Piperidin-1-yl-ethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
2-({6-[3-(2-Pyridin-4-yl-thiazol-4-yl)-ureido]-pyridin-2-ylamino}-methyl)-piperidine-1-carboxylic acid tert-butyl ester;
1-{6-[(Piperidin-2-ylmethyl)-amino]-pyridin-2-yl}-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
(S)-1-[6-(3-Methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
(R)-1-[6-(3-Methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(2-Chloro-thiazol-4-yl)-3-(6-piperidin-1-ylmethyl-pyridin-2-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6-(2-piperidin-4-yl-ethoxy)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(2-piperidin-4-yl-ethoxy)-pyridin-2-yl]-urea;
1-[6-(Azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-bromo-thiazol-4-yl)-urea;
1-[6-(Azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-chloro-thiazol-4-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6-(piperidin-4-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(piperidin-4-ylmethoxy)-pyridin-2-yl]-urea;
3-(4-{3-[6-(1-Methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-ureido}-thiazol-2-yl)-benzenesulfonamide;
tert-Butyl 3-{6-[3-(2-pyridin-4-yl-thiazol-4-yl)-ureido]-pyridin-2-yloxymethyl}-pyrrolidine-1-carboxylate;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-[6-(pyrrolidin-3-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-Cyclopropyl-thiazol-4-yl)-3-[6-(2-piperidin-4-yl-ethoxy)-pyridin-2-yl]-urea;
Isopropyl-{6-[3-(2-pyridin-4-yl-thiazol-4-yl)-ureido]-pyridin-2-ylmethyl}-carbamic acid tert-butyl ester;
1-[6-(Isopropylamino-methyl)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
Isopropyl-{6-[3-(2-phenyl-thiazol-4-yl)-ureido]-pyridin-2-ylmethyl}-carbamic acid tert-butyl ester;
1-[6-(Isopropylamino-methyl)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6-(1-methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(1-methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
1-(2-phenylthiazol-4-yl)-3-(6-p-pyrrolidin-1-ylmethylphenoxypyridin-2-yl)urea;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-[6-(tetrahydro-furan-3-yloxy)-pyridin-2-yl]-urea;
1-[2-(1H-Indazol-5-yl)-thiazol-4-yl]-3-(6-piperidin-1-ylmethyl-pyridin-2-yl)-urea;
1-(1′
-Methyl-1′
,2′
,3′
,6′
-tetrahydro-[2,4′
]bipyridinyl-6-yl)-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(2-Bromo-thizol-4-yl)-3-(1′
-methyl-1′
,2′
,3′
,6′
-tetrahydro-[2,4′
]bipyridinyl-6-yl)-urea;
1-(1′
-Methyl-1′
,2′
,3′
,6′
-tetrahydro-2[2,4]bipyridinyl-6-yl)-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(3-Hydroxy-propylamino)-pyridin-2-yl]-3-(2-pyridin-4-yl-thizol-4-yl)-urea;
1-(2-Bromo-thiazol-4-yl)-3-[6(3-hydroxy-propylamino)-pyridin-2-yl]-urea;
1-(1′
-Methyl-1′
,2′
,3′
,4′
,5′
,6′
-hexahydro-[2,4′
]bipydrinyl-6-yl)-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(1′
-Methyl-1′
,2′
,3′
,4′
,5′
,6′
-hexahydro-[2,4′
]bipyridinyl-6-yl)-3-(2-phenyl-thiazol-4-yl)-urea;
6-[3-(2-Pyridin-4-yl-thizol-4-yl)-ureido]-3′
,6′
-dihydro-2′
H-[2,4]bipyridinyl-l′
-carboxylic acid tert-butylester;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-(1′
,2′
,3′
,6′
-tetrahydro-[2,4′
]bipyridinyl-6-yl)-urea;
1-(2-Pyridin-4-yl-thizol-4-yl)-3-[6-(tetrahydro-furan-3-ylmethoxy)-pyridin-2-yl]-urea;
2-[6-[3-(2-Pyridin-4-yl-thiazol-4-yl)-ureido]-pyridin-2-yloxymethyl]-pyrrolidine-1-carboxylic acid tert-butyl ester;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-[6-(pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
6-[3-(2-Pyridin-4-yl-thiazol-4-yl)-ureido]-pyridine-2-carbothioic acid diethylamide;
1-(2-Bromo-thiazol-4-yl)-3-[6-(3-methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-urea;
1-(2-Chloro-thiazol-4-yl)-3-[6-(3-methyl-piperidin-1-ylmethyl)-pyridin-2-yl]-urea;
1-[2-(2-Methoxy-pyridin-4-yl)-thiazol-4-yl]-3-[6-(1-methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-urea;
1-[6-(2-Dimethylamino-ethoxy)-pyridin-2-yl]-3-[2-(2-methoxy-pyridin-4-yl)-thiazol-4-yl]-urea;
1-[6-(1-Methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-(2-phenylthiazol-4-yl)-3-(6-pyrrolidin-1-ylmethyl-pyridin-2-yl)urea;
1-(6-Diethylaminomethylpyridin-2-yl)-3-(2-phenylthiazol-4-yl)urea;
(S)-1-[6-(1-Methylpyrrolidin-2-ylmethoxy)pyridin-2-yl]-3-(2-phenylthiazol-4-yl)urea;
1-[6-(2-Piperidin-4-yl-ethoxy)pyridin-2-yl]-3-[2-phenylthiazol-4-yl]urea;
1-[6-(4-Ethylpiperazin-1-yl)-pyridin-2-yl]-3-(2-phenylthiazol-4-yl)urea;
1-(2-phenylthiazol-4-yl)-3-[6-(4-pyrimidin-2-yl-piperazin-1-yl)pyridin-2-yl]urea;
Diethyl 6-[3-(2-phenylthiazol-4-yl)ureido]-pyridine-2-carboxamide;
1-(2-Pyridin-4-yl-thiazol-4-yl)-3-(6-p-pyrrolidin-1-ylmethylphenoxypyridin-2-yl)urea;
1-(2-Bromothiazol-4-yl)-3-(6-p-pyrrolidin-1-ylmethylphenoxypyridin-2-yl)urea;
1-[6-(Piperidin-4-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-piperidin-4-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-piperidin-4-yloxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-pyridin-4-yl-thiazol-4-yl)-urea;
1-[6-(Azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-azetidin-3-ylmethoxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-(2-Phenyl-thiazol-4-yl)-3-[6-(piperidin-4-ylmethoxy)-pyridin-2-yl]-urea;
1-[6-(1-Methyl-piperidin-4-ylmethoxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-piperidin-4-yloxy)-pyridin-2-yl]-3-(2-phenyl-thiazol-4-yl)-urea;
1-[6-(2-Piperidin-4-yl-ethoxy)-pyridin-2-yl]-3-(2-thiophen-2-yl-thiazol-4-yl)-urea;
1-[6-(1-Methyl-pyrrolidin-2-ylmethoxy)-pyridin-2-yl]-3-[2-(thiophene-2-sulfonylmethyl)-thiazol-4-yl]-urea;
1-[2-(2-Methoxy-pyridin-4-yl)-thiazol-4-yl]-3-(6-piperdin-1-ylmethyl-pyridin-2-yl)-urea; and
[2-(2-Chloro-pyridin-4-yl)-thiazol-4-yl]-3-(6-piperdin-1-ylmethyl-pyridin-2-yl)-urea.
-
-
13. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of claim 1.
-
14. A method of inhibiting cell proliferation which comprises administering an effective amount of a compound of claim 1.
-
15. A method of treating cancer which comprises administering an effective amount of a compound of claim 1.
-
16. A method of inhibiting a serine/threonine kinase which comprises administering an effective amount of a compound of claim 1.
-
17. A method of treating a neurological disorder which comprises administering an effective amount of a compound of claim 1.
-
2. A compound of claim 1 wherein R15 is selected from H, optionally substituted pyrrolidinyl, optionally substituted piperazinyl, optionally substituted piperidinyl, morpholinyl, 1,2,3,6-tetrahydro-pyridinyl, (optionally substituted pyrrolidinyl) -C1-C2-alkyl, (optionally substituted piperidinyl) -C1-C2-alkyl, (optionally substituted piperazinyl) -C1-C2-alkyl, morpholinyl-C1-C2-alkyl, C1-C4-alkylamino-C1-C4-alkyl, C1-C4-hydroxyalkylamino, (optionally substituted pyrrolidinyl) -C1-C2-alkylamino, (optionally substituted piperidinyl) -C1-C2-alkylamino, (optionally substituted piperazinyl) -C1-C2-alkylamino, morpholinyl-C1-C2-alkylamino, optionally substituted pyrrolidinyl-C1-C4-alkoxy, optionally substituted azetidinyl-C1-C4-alkoxy, tetrahydrofuryl-C1-C4-alkoxy, optionally substituted piperidinyl-C1-C4-alkoxy, C1-C4-alkylamino-C1-C4-alkoxy, tetrahydrofuryloxy, optionally substituted piperidinyloxy, optionally substituted phenoxy, C1-C4-alkylaminocarbonyl and C1-C4-alkylaminothiocarbonyl;
Specification
- Resources
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeAmgen Inc.
-
Original AssigneeAmgen Inc.
-
InventorsSantora, Vincent, Liu, Gang, Lopez, Patricia, Tegley, Christopher, Li, Aiwen, Yang, Kevin, De Morin, Frenel F., Askew, Benny C., Nomak, Rana, Laber, Ellen, Hague, Andrew
-
Granted Patent
-
Time in Patent OfficeDays
-
Field of Search
-
US Class Current514/318
-
CPC Class CodesA61P 1/04 for ulcers, gastritis or re...A61P 13/08 of the prostateA61P 13/12 of the kidneysA61P 17/02 for treating wounds, ulcers...A61P 17/06 AntipsoriaticsA61P 19/02 for joint disorders, e.g. a...A61P 25/00 Drugs for disorders of the ...A61P 25/14 for treating abnormal movem...A61P 25/16 Anti-Parkinson drugsA61P 25/28 for treating neurodegenerat...A61P 27/02 Ophthalmic agentsA61P 27/16 OtologicalsA61P 29/00 Non-central analgesic, anti...A61P 3/10 for hyperglycaemia, e.g. an...A61P 35/00 Antineoplastic agentsA61P 43/00 Drugs for specific purposes...A61P 7/00 Drugs for disorders of the ...A61P 9/00 Drugs for disorders of the ...A61P 9/10 for treating ischaemic or a...C07D 213/75 Amino or imino radicals, ac...C07D 231/12 : with only hydrogen atoms, h...C07D 233/56 : with only hydrogen atoms or...C07D 249/08 : 1,2,4-Triazoles; Hydrogenat...C07D 417/04 : directly linked by a ring-m...C07D 417/12 : linked by a chain containin...C07D 417/14 : containing three or more he...C07D 453/06 : containing isoquinuclidine ...C07D 471/04 : Ortho-condensed systemsC07D 491/10 : Spiro-condensed systems